Quality standards for the management of non-alcoholic fatty liver disease (NAFLD): consensus recommendations from the British Association for the Study of the Liver and British Society of Gastroenterology NAFLD Special Interest Group

Autor: McPherson S, Armstrong MJ, Cobbold JF, Corless L, Anstee QM, Aspinall RJ, Barclay ST, Brennan PN, Cacciottolo TM, Goldin RD, Hallsworth K, Hebditch V, Jack K, Jarvis H, Johnson J, Li W, Mansour D, McCallum M, Mukhopadhya A, Parker R, Ross V, Rowe IA, Srivastava A, Thiagarajan P, Thompson AI, Tomlinson J, Tsochatzis EA, Yeoman A, Alazawi W

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::990403594a1fc64325d7e1e7d4f1221b

A narrative review of lifestyle management guidelines for metabolic dysfunction-associated steatotic liver disease.

Autor: Ivancovsky Wajcman D; Barcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona, Barcelona, Spain.; The Global NASH Council, Washington DC, USA., Byrne CJ; Division of Molecular and Clinical Medicine, Ninewells Hospital and Medical School, University of Dundee, Dundee, United Kingdom., Dillon JF; Division of Molecular and Clinical Medicine, Ninewells Hospital and Medical School, University of Dundee, Dundee, United Kingdom., Brennan PN; The Global NASH Council, Washington DC, USA.; Division of Molecular and Clinical Medicine, Ninewells Hospital and Medical School, University of Dundee, Dundee, United Kingdom., Villota-Rivas M; Barcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona, Barcelona, Spain., Younossi ZM; The Global NASH Council, Washington DC, USA.; Beatty Liver and Obesity Research Program, Inova Health System, Falls Church, VA, USA., Allen AM; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA., Crespo J; Valdecilla Research Institute (IDIVAL), Marqués de Valdecilla University Hospital, Santander, Spain., Gerber LH; The Global NASH Council, Washington DC, USA.; Beatty Liver and Obesity Research Program, Inova Health System, Falls Church, VA, USA., Lazarus JV; Barcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona, Barcelona, Spain.; The Global NASH Council, Washington DC, USA.; City University of New York Graduate School of Public Health and Health Policy (CUNY SPH), New York, NY, USA.; Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.

Publikováno v: Hepatology (Baltimore, Md.) [Hepatology] 2024 Aug 15. Date of Electronic Publication: 2024 Aug 15.

Progress is impossible without change: understanding the evolving nomenclature of steatotic liver disease and its effect on hepatology practice.

Autor: Brennan PN; Division of Clinical and Molecular Medicine, University of Dundee, Ninewells Hospital and Medical School, Dundee, UK., Tavabie OD; Leeds Liver Unit, St James's University Hospital, Leeds, UK., Li W; Barts Liver Centre, Blizard Institute, Queen Mary University of London, London, UK., Marjot T; Oxford Centre for Diabetes Endocrinology and Metabolism, NIHR Oxford Biomedical Research Centre, Churchill Hospital, University of Oxford, Oxford, UK., Corless L; Department of Gastroenterology, Hepatology and Endoscopy, Hull University Teaching Hospitals NHS Trust, Hull, UK; Hull York Medical School, Hull, UK., Fallowfield JA; Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK., Jarvis H; Population Heath Sciences Institute, Newcastle University, Newcastle, UK., Mansour D; Department of Gastroenterology and Hepatology Queen Elizabeth Hospital, Gateshead and Translational and Clinical Research Institute, Newcastle University, Newcastle, UK., McPherson S; Liver unit, The Newcastle upon Tyne Hospital NHS Foundation Trust and Translational and Clinical Research Institute, Newcastle University, Newcastle, UK., Rosenberg W; UCL Institute for Liver and Digestive Health, Royal Free Hospital and UCL, London, UK., Rockell K; UK Organ Donation and Transplantation Research Network, UK., Tomlinson J; Oxford Centre for Diabetes Endocrinology and Metabolism, NIHR Oxford Biomedical Research Centre, Churchill Hospital, University of Oxford, Oxford, UK., Yeoman A; Gwent Liver Unit, Aneurin Bevan University Health Board, Newport, UK., Tsochatzis EA; UCL Institute for Liver and Digestive Health, Royal Free Hospital and UCL, London, UK., Dillon JF; Division of Clinical and Molecular Medicine, University of Dundee, Ninewells Hospital and Medical School, Dundee, UK., Alazawi W; Barts Liver Centre, Blizard Institute, Queen Mary University of London, London, UK., Abeysekera KWM; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK. Electronic address: k.abeysekera@bristol.ac.uk.

Publikováno v: The lancet. Gastroenterology & hepatology [Lancet Gastroenterol Hepatol] 2024 Jun; Vol. 9 (6), pp. 577-582. Date of Electronic Publication: 2024 Feb 28.

Beyond a liver-gut focus: the evolution of gastroenterology and hepatology in challenging the obesity and steatotic liver disease paradigm.

Autor: Brennan PN; University of Dundee, Division of Molecular and Clinical Medicine, Ninewells Hospital and Medical School, Dundee, UK.; Department of Gastroenterology, NHS Tayside, Ninewells Hospital and Medical School, Dundee, UK., Zelber-Sagi S; School of Public Health, Faculty of Social Welfare and Health Sciences, University of Haifa, Haifa, Israel., Allen AM; Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA., Dillon JF; University of Dundee, Division of Molecular and Clinical Medicine, Ninewells Hospital and Medical School, Dundee, UK.; Department of Gastroenterology, NHS Tayside, Ninewells Hospital and Medical School, Dundee, UK., Lazarus JV; CUNY Graduate School of Public Health and Health Policy (CUNY SPH), New York, New York, USA Jeffrey.Lazarus@sph.cuny.edu.; Barcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona, Barcelona, Spain.

Publikováno v: Gut [Gut] 2024 Mar 07; Vol. 73 (4), pp. 560-563. Date of Electronic Publication: 2024 Mar 07.

A global action agenda for turning the tide on fatty liver disease.

Autor: Lazarus JV; Barcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona, Barcelona, Spain.; Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.; CUNY Graduate School of Public Health and Health Policy (CUNY SPH), New York, New York, USA., Mark HE; European Association for the Study of the Liver (EASL), Geneva, Switzerland.; Independent consultant, Nottingham, UK., Allen AM; Department of Medicine, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA., Arab JP; Department of Medicine, Division of Gastroenterology, Schulich School of Medicine, Western University & London Health Sciences Centre, London, Ontario, Canada.; Department of Epidemiology and Biostatistics, Schulich School of Medicine, Western University, London, Ontario, Canada.; Department of Gastroenterology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile., Carrieri P; Aix Marseille Univ, Inserm, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, ISSPAM, Marseille, France., Noureddin M; Houston Methodist Hospital, Houston Research Institute, Houston, Texas, USA., Alazawi W; Barts Liver Centre, Blizard Institute, Queen Mary University of London, London, UK., Alkhouri N; Fatty Liver Program, Arizona Liver Health, Phoenix, Arizona, USA., Alqahtani SA; King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia., Anstee QM; Translational & Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK., Arrese M; Department of Gastroenterology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile., Bataller R; Liver Unit, Hospital Clínic, University of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain., Berg T; Department of Medicine II, Division of Hepatology, Leipzig University Medical Center, Leipzig, Germany., Brennan PN; Division of Hepatology, University of Dundee, Dundee, Scotland, UK., Burra P; Multivisceral Transplant Unit-Gastroenterology, Department of Surgery, Oncology and Gastroenterology at the Padua University Hospital, Padua, Italy., Castro-Narro GE; Department of Hepatology and Transplant, Hospital Médica Sur, Mexico City, Mexico.; Department of Gastroenterology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.; Asociación Latinoamericana para el Estudio del Hígado (ALEH), Santiago, Chile., Cortez-Pinto H; Clinica Universitária de Gastrenterologia, Laboratório de Nutrição, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal., Cusi K; Department of Medicine, Division of Endocrinology, Diabetes & Metabolism, University of Florida, Gainesville, Florida, USA., Dedes N; Greek Patients Association, Athens, Greece., Duseja A; Department of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh, India., Francque SM; Department of Gastroenterology and Hepatology, Antwerp University Hospital, Edegem, Belgium.; InflaMed Centre of Excellence, Laboratory for Experimental Medicine and Paediatrics, Translational Sciences in Inflammation and Immunology, Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Belgium., Gastaldelli A; Institute of Clinical Physiology, National Research Council, Pisa, Italy., Hagström H; Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden., Huang TTK; CUNY Graduate School of Public Health and Health Policy (CUNY SPH), New York, New York, USA.; CUNY Center for Systems and Community Design and NYU-CUNY Prevention Research Center, New York, New York, USA., Ivancovsky Wajcman D; Barcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona, Barcelona, Spain., Kautz A; Kautz 5 gUG, Köln, Germany., Kopka CJ; Independent researcher, Ponte de Lima, Portugal., Krag A; Department of Gastroenterology and Hepatology, Odense University Hospital, Odense, Denmark., Newsome PN; National Institute for Health Research Birmingham Biomedical Research Centre at University Hospitals Birmingham NHS Foundation Trust and the University of Birmingham, Birmingham, UK., Rinella ME; Department of Medicine, University of Chicago, Chicago, Illinois, USA., Romero D; Department of Community Health and Social Sciences, CUNY Graduate School of Public Health and Health Policy, New York, New York, USA., Sarin SK; Department of Hepatology, Institute of Liver and Biliary Sciences, New Delhi, India., Silva M; Hepatology and Clinical Research Units, Hospital Universitario Austral, Buenos Aires, Argentina., Spearman CW; Department of Medicine, Division of Hepatology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa., Terrault NA; Gastrointestinal and Liver Disease Division, University of Southern California, Los Angeles, California, USA., Tsochatzis EA; UCL Institute for Liver and Digestive Health, Royal Free Hospital, London, UK., Valenti L; Precision Medicine, Biological Resource Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.; Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy., Villota-Rivas M; Barcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona, Barcelona, Spain., Zelber-Sagi S; School of Public Health, Faculty of Social Welfare and Health Sciences, University of Haifa, Haifa, Israel.; Department of Gastroenterology, Tel Aviv Medical Centre, Tel Aviv, Israel., Schattenberg JM; Metabolic Liver Research Program, I. Department of Medicine, University Medical Centre Mainz, Mainz, Germany., Wong VW; The Chinese University of Hong Kong, Hong Kong, China., Younossi ZM; Center for Liver Disease, Inova, Falls Church, Virginia, USA.

Publikováno v: Hepatology (Baltimore, Md.) [Hepatology] 2024 Feb 01; Vol. 79 (2), pp. 502-523. Date of Electronic Publication: 2023 Aug 04.